Healthcare

Craif

AI-powered urine test that screens for early-stage cancer risk

Visit Craif
1 viewsPricing · PaidHot
The Falcoscan Intel Panel/Craif · Healthcare
Live market data
Opportunity
84
Strong/ 100
Saturation
11
Open/ 100
Wrapper Risk
9
Open/ 100
Signal
Hot
Market trend
The Brief

What Craif does

Craif, formerly Icaria, developed miSignal, a urine-based test that uses what the company calls "Bio AI" to analyze microRNA patterns and assess cancer risk across multiple organs. Craif partners with roughly 50 university hospitals and cancer research centers across Japan to offer the test and is also developing miAge, a biological-age assessment test. The company operates a research lab in Nagoya and opened a lab in San Diego in April 2026 to support US expansion, while its headquarters remains in Tokyo. The round is a global raise backed by both venture investors and several Japanese regional banks, per the company's announcement.

Builder’s Brief

Craif is a healthcare tool on Falcoscan. AI-powered urine test that screens for early-stage cancer risk. Falcoscan rates Craif with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: hot. Craif is founded in 2018, currently at Series_d_plus stage. Pricing: Paid.

Market position · Healthcare

How Craif compares in Healthcare

Craif's opportunity score of 84 ranks #41 of 137 live Healthcare tools on Falcoscan, 2.2 points above the category average of 81.8. Its saturation score is 11/100, against a category average of 11. 75 of the 137 live Healthcare tools carry a hot signal, and Falcoscan has recorded 8 shutdowns in the category.

Craif compared with top-rated Healthcare tools
ProductOpportunitySaturationPricingSignal
Craif8411PaidHot
DeepMind AlphaFold886FreeHot
Nuance DAX Copilot9012PaidHot
Viz.ai AI Stroke Response906PaidHot
Tempus AI Diagnostics886PaidHot
Viz.ai Stroke AI888PaidHot
What it ships with

Capabilities & who uses it

The capabilities Craif exposes to builders and the verticals it currently serves.

AI Capabilities
Biomarker AnalysisCancer Risk ScoringMolecular Diagnostics
Industry Verticals
HealthcareBiotechDiagnostics
Tagged

Craif shows up when builders search for these

cancer-screeningbio-aimicrorna-analysisdiagnosticsearly-detection
Similar tools · Healthcare

Alternatives to Craif

The top-rated live healthcare tools tracked on Falcoscan, ranked by Falcoscan rating within the category.

See the Healthcare market
Healthcare
DeepMind AlphaFold

AI protein structure prediction for drug discovery

★ 4.9Opp 88
Free
Healthcare
Nuance DAX Copilot

AI clinical documentation assistant for physicians

★ 4.8Opp 90
Paid
Healthcare
Viz.ai AI Stroke Response

AI stroke detection and care coordination platform

★ 4.8Opp 90
Paid
Healthcare
Tempus AI Diagnostics

AI liquid biopsy analysis for early cancer detection

★ 4.8Opp 88
Paid
Healthcare
Viz.ai Stroke AI

AI triage and coordination platform for stroke care

★ 4.8Opp 88
Paid
Healthcare
Anterior AI Insurance

AI prior authorization automation for health insurance

★ 4.7Opp 88
Paid
Questions

Craif: common questions

Is Craif free?

No. Craif is a paid product.

What are the best alternatives to Craif?

The top-rated live Healthcare tools on Falcoscan, other than Craif, are DeepMind AlphaFold, Nuance DAX Copilot, Viz.ai AI Stroke Response, Tempus AI Diagnostics, and Viz.ai Stroke AI.

Is Craif still operating?

Yes. Falcoscan's operating checks list Craif as active.

Where is Craif based?

Craif is headquartered in Tokyo, Japan.

Does Craif have an API?

Falcoscan's records show no public API for Craif.

Who is Craif for?

Craif is built for hospitals, research centers, and consumers.

Back to Browse